Induction of Apoptosis, Inhibition of MCL-1, and VEGF-A Expression Are Associated with the Anti-Cancer Efficacy of Magnolol Combined with Regorafenib in Hepatocellular Carcinoma

SIMPLE SUMMARY: The synergistic inhibition of hepatocellular carcinoma growth was induced by administering magnolol together with regorafenib, instead of each treatment individually. Hepatocellular carcinoma (HCC) cells were sensitized to regorafenib through the inhibition of the expression of both...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng-Hsien, Hsu, Fei-Ting, Chen, Wei-Lung, Chen, Jiann-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123296/
https://www.ncbi.nlm.nih.gov/pubmed/33922992
http://dx.doi.org/10.3390/cancers13092066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123296/
https://www.ncbi.nlm.nih.gov/pubmed/33922992
http://dx.doi.org/10.3390/cancers13092066

Ejemplares similares